Contract Pharmacal Corporation India Private Limited, a active foreign private limited company, was established on 13 June 2013 in Ahmedabad, Gujarat, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73200GJ2013FTC075586. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.95 Cr.
It upholds a compliant status. Employing 24 professional, Its leadership includes Ketan Babulal Dalki (Additional Director), Matthew David Wolf (Director), Mark Nathan Wolf (Director). Past directors included Vineet Aneja, Robyn Eagle Allison Wolf, Matthew David Wolf. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sefron I Park, Plot No. 42 Pancharatna Industrial Estate Part-3, Ch, Angodar, Ahmedabad, Gujarat, 382213.
U73200GJ2013FTC075586
075586
13 June 2013
₹6.00 Cr
₹4.95 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Contract Pharmacal Corporation India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ketan Babulal Dalki | Additional Director | 14 Apr 2022 | Current |
| Matthew David Wolf | Director | 24 Jun 2013 | Current |
| Mark Nathan Wolf | Director | 24 Jun 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Mar 2014 | Past |
| Pramod Abcsdd | Director | 01 Oct 2021 | Past |
| Pramod Abcsdd | Additional Director | 22 Dec 2014 | Past |
| Pramod Abcsdd | Additional Director | 22 Dec 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 09 May 2022 | Past |
| Pramod Abcsdd | Director | 24 Jan 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Contract Pharmacal Corporation India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.84% decrease. The company also saw a substantial fall in profitability, with a 52.6% decrease in profit. The company's net worth moved up by a moderate rise of 6.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Contract Pharmacal Corporation India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Contract Pharmacal Corporation India has a workforce of 24 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Contract Pharmacal Corporation India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Contract Pharmacal Corporation India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Contract Pharmacal Corporation India Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was completed.
The activity Contract Pharmacal Corporation India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on Ketan Babulal Dalki was appointed as a Additional Director was appointed as a Additional Director on 14 Apr 2022 & has been associated with this company since 3 years 7 months . was documented.
Progress on Matthew David Wolf was appointed as a Director was appointed as a Director on 24 Jun 2013 & has been associated with this company since 12 years 5 months . was documented.
The activity Mark Nathan Wolf was appointed as a Director was appointed as a Director on 24 Jun 2013 & has been associated with this company since 12 years 5 months . was completed.
Contract Pharmacal Corporation India Private Limited was registered on 13 Jun 2013 with Roc Ahmedabad & aged 12 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Contract Pharmacal Corporation India Private Limited is U73200GJ2013FTC075586.
Contract Pharmacal Corporation India Private Limited is headquartered at Sefron I Park, Plot No. 42 Pancharatna Industrial Estate Part-3, Ch, Angodar, Ahmedabad, Gujarat, 382213.
Contract Pharmacal Corporation India Private Limited was incorporated on 13 June 2013.
The current directors of Contract Pharmacal Corporation India Private Limited are
The primary industry of Contract Pharmacal Corporation India Private Limited is Professional, Scientific And Technical.
Contract Pharmacal Corporation India Private Limited is unlisted.
The authorized capital of Contract Pharmacal Corporation India Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.95 Cr.
The compliance status of Contract Pharmacal Corporation India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX